FYERS
Home
/
Stocks
/
Results
/
Advanced Enzyme Technologies Results

Advanced Enzyme Technologies Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
10%8%11%17%
8%3%17%30%
-1%-5%-3%-13%
15%11%11%11%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
ADVENZYMES
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
293₹3326 Cr20.053.3118.42₹169 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
————————————————
₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹22 Cr₹21 Cr₹21 Cr
₹9 Cr₹5 Cr₹3 Cr₹0₹64 L₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹30 L₹0₹0₹0₹0₹0₹0
₹1600 Cr₹1394 Cr₹1299 Cr₹1213 Cr₹1066 Cr₹946 Cr₹814 Cr₹653 Cr₹534 Cr₹441 Cr₹256 Cr₹190 Cr₹146 Cr₹142 Cr₹76 Cr₹43 Cr
₹1600 Cr₹1394 Cr₹1299 Cr₹1213 Cr₹1066 Cr₹946 Cr₹814 Cr₹653 Cr₹534 Cr₹441 Cr₹256 Cr₹190 Cr₹146 Cr₹142 Cr₹76 Cr₹43 Cr
₹1632 Cr₹1421 Cr₹1324 Cr₹1235 Cr₹1089 Cr₹971 Cr₹840 Cr₹679 Cr₹559 Cr₹464 Cr₹278 Cr₹212 Cr₹167 Cr₹163 Cr₹97 Cr₹63 Cr
₹51 Cr₹48 Cr₹47 Cr₹49 Cr₹52 Cr₹62 Cr₹28 Cr₹26 Cr₹23 Cr₹21 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr
₹8 Cr₹9 Cr₹7 Cr₹8 Cr₹8 Cr₹10 Cr₹3 Cr₹6 Cr₹17 Cr₹16 Cr₹35 Cr₹49 Cr₹82 Cr₹108 Cr₹132 Cr₹28 Cr
₹0₹0₹0₹0₹0₹18 L₹72 L₹1 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr₹6 Cr₹8 Cr₹7 Cr₹9 Cr
₹27 Cr₹23 Cr₹20 Cr₹26 Cr₹32 Cr₹34 Cr₹25 Cr₹22 Cr₹22 Cr₹12 Cr₹17 Cr₹10 Cr₹6 Cr₹13 Cr₹7 Cr₹7 Cr
₹4 Cr₹12 Cr₹16 Cr₹15 Cr₹18 Cr₹4 Cr₹8 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹5 Cr₹2 Cr₹89 L₹51 L₹1 Cr₹1 Cr₹1 Cr₹55 L₹1 Cr₹79 L₹18 L₹0₹0₹0₹0₹0
₹44 Cr₹46 Cr₹44 Cr₹49 Cr₹59 Cr₹49 Cr₹39 Cr₹30 Cr₹43 Cr₹32 Cr₹56 Cr₹64 Cr₹94 Cr₹130 Cr₹146 Cr₹44 Cr
————————————————
₹40 Cr₹19 Cr₹16 Cr₹24 Cr₹18 Cr₹15 Cr₹10 Cr₹10 Cr₹17 Cr₹11 Cr₹12 Cr₹12 Cr₹10 Cr₹17 Cr₹18 Cr₹8 Cr
₹48 Cr₹40 Cr₹44 Cr₹43 Cr₹37 Cr₹43 Cr₹34 Cr₹29 Cr₹38 Cr₹21 Cr₹59 Cr₹83 Cr₹60 Cr₹44 Cr₹42 Cr₹7 Cr
₹11 Cr₹11 Cr₹18 Cr₹5 Cr₹2 Cr₹5 Cr₹13 Cr₹21 Cr₹38 Cr₹27 Cr₹30 Cr₹24 Cr₹39 Cr₹33 Cr₹38 Cr₹27 Cr
₹7 Cr₹25 Cr₹29 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹6 Cr₹3 Cr₹10 Cr₹13 Cr₹23 Cr₹7 Cr₹6 Cr₹3 Cr
₹107 Cr₹96 Cr₹106 Cr₹78 Cr₹60 Cr₹68 Cr₹60 Cr₹65 Cr₹99 Cr₹62 Cr₹111 Cr₹131 Cr₹133 Cr₹100 Cr₹105 Cr₹45 Cr
₹1834 Cr₹1611 Cr₹1521 Cr₹1411 Cr₹1260 Cr₹1149 Cr₹971 Cr₹805 Cr₹727 Cr₹583 Cr₹450 Cr₹412 Cr₹398 Cr₹396 Cr₹349 Cr₹154 Cr
₹8 Cr₹9 Cr₹5 Cr₹5 Cr₹13 Cr₹11 Cr₹14 Cr₹29 Cr₹29 Cr₹25 Cr₹19 Cr₹41 Cr₹59 Cr₹10 Cr₹92 L₹0
₹21 Cr₹22 Cr₹25 Cr₹13 Cr₹11 Cr₹19 Cr₹26 Cr₹35 Cr₹67 Cr₹54 Cr₹101 Cr₹115 Cr₹167 Cr₹184 Cr₹206 Cr₹65 Cr
————————————————
₹1018 Cr₹966 Cr₹902 Cr₹868 Cr₹806 Cr₹756 Cr₹681 Cr₹586 Cr₹561 Cr₹445 Cr₹358 Cr₹346 Cr₹343 Cr₹334 Cr₹244 Cr₹87 Cr
₹326 Cr₹287 Cr₹252 Cr₹219 Cr₹187 Cr₹152 Cr₹118 Cr₹91 Cr₹70 Cr₹24 Cr₹72 Cr₹64 Cr₹57 Cr₹47 Cr₹39 Cr₹35 Cr
₹692 Cr₹679 Cr₹650 Cr₹649 Cr₹619 Cr₹604 Cr₹563 Cr₹495 Cr₹491 Cr₹421 Cr₹285 Cr₹282 Cr₹286 Cr₹287 Cr₹204 Cr₹51 Cr
₹51 Cr₹22 Cr₹31 Cr₹16 Cr₹10 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹1 Cr₹2 Cr₹5 Cr₹2 Cr₹2 Cr₹60 Cr₹19 Cr
₹6 L₹7 L₹17 L₹17 L₹7 L₹7 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L
₹6 L₹7 L₹17 L₹17 L₹7 L₹7 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L₹6 L
₹40 Cr₹24 Cr₹19 Cr₹16 Cr₹18 Cr₹15 Cr₹17 Cr₹11 Cr₹9 Cr₹9 Cr₹18 Cr₹16 Cr₹17 Cr₹12 Cr₹8 Cr₹20 Cr
₹6 Cr₹7 Cr₹1 Cr₹1 Cr₹4 Cr₹4 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹13 L₹4 L₹11 L₹1 Cr₹9 L₹20,000
₹790 Cr₹731 Cr₹711 Cr₹688 Cr₹656 Cr₹633 Cr₹591 Cr₹518 Cr₹512 Cr₹440 Cr₹311 Cr₹307 Cr₹306 Cr₹302 Cr₹273 Cr₹90 Cr
————————————————
₹584 Cr₹480 Cr₹403 Cr₹360 Cr₹102 Cr₹121 Cr₹124 Cr₹111 Cr₹40,000₹40,000₹0₹0₹0₹0₹0₹0
₹177 Cr₹157 Cr₹148 Cr₹124 Cr₹121 Cr₹94 Cr₹80 Cr₹77 Cr₹76 Cr₹68 Cr₹60 Cr₹53 Cr₹50 Cr₹45 Cr₹29 Cr₹18 Cr
₹145 Cr₹115 Cr₹99 Cr₹100 Cr₹88 Cr₹86 Cr₹75 Cr₹59 Cr₹59 Cr₹50 Cr₹42 Cr₹37 Cr₹32 Cr₹39 Cr₹32 Cr₹22 Cr
₹116 Cr₹108 Cr₹127 Cr₹123 Cr₹274 Cr₹198 Cr₹83 Cr₹23 Cr₹61 Cr₹8 Cr₹26 Cr₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹15 Cr
₹9 Cr₹8 Cr₹9 Cr₹6 Cr₹8 Cr₹9 Cr₹8 Cr₹9 Cr₹8 Cr₹3 Cr₹8 Cr₹72 L₹6 L₹3 L₹25,573₹63,269
₹13 Cr₹11 Cr₹24 Cr₹9 Cr₹12 Cr₹8 Cr₹7 Cr₹3 Cr₹7 Cr₹9 Cr₹3 Cr₹9 Cr₹7 Cr₹7 Cr₹10 Cr₹9 Cr
₹1044 Cr₹880 Cr₹810 Cr₹722 Cr₹604 Cr₹516 Cr₹376 Cr₹282 Cr₹211 Cr₹138 Cr₹140 Cr₹104 Cr₹92 Cr₹94 Cr₹77 Cr₹64 Cr
₹937 Cr₹784 Cr₹703 Cr₹645 Cr₹544 Cr₹448 Cr₹316 Cr₹217 Cr₹112 Cr₹76 Cr₹29 Cr-₹27 Cr-₹41 Cr-₹6 Cr-₹28 Cr₹18 Cr
₹1834 Cr₹1611 Cr₹1521 Cr₹1411 Cr₹1260 Cr₹1149 Cr₹971 Cr₹805 Cr₹727 Cr₹583 Cr₹450 Cr₹412 Cr₹398 Cr₹396 Cr₹349 Cr₹154 Cr
₹145₹127₹118₹110₹97₹87₹75₹60₹50₹208₹128₹97₹77₹75₹47₹31
₹145₹127₹118₹110₹97₹87₹75₹60₹50₹42₹26₹19₹15₹15₹9₹6

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
₹233 Cr₹187 Cr₹188 Cr₹140 Cr₹171 Cr₹210 Cr₹179 Cr₹162 Cr₹139 Cr₹137 Cr₹118 Cr₹75 Cr₹28 Cr₹77 Cr₹48 Cr₹19 Cr
₹4 Cr₹27 Cr₹29 Cr₹37 Cr₹33 Cr₹25 Cr₹28 Cr₹26 Cr₹27 Cr₹18 Cr₹15 Cr₹17 Cr₹21 Cr₹15 Cr₹17 Cr₹6 Cr
-₹15 Cr-₹12 Cr-₹26 Cr-₹34 L-₹27 Cr-₹15 Cr-₹16 Cr-₹12 Cr-₹6 Cr₹4 Cr-₹13 Cr-₹12 Cr₹26 Cr-₹26 Cr₹37 Cr-₹19 Cr
₹222 Cr₹202 Cr₹191 Cr₹177 Cr₹177 Cr₹220 Cr₹192 Cr₹176 Cr₹160 Cr₹160 Cr₹120 Cr₹80 Cr₹75 Cr₹67 Cr₹101 Cr₹6 Cr
₹157 Cr₹142 Cr₹141 Cr₹140 Cr₹122 Cr₹163 Cr₹141 Cr₹129 Cr₹116 Cr₹107 Cr₹93 Cr₹54 Cr₹56 Cr₹41 Cr₹88 Cr₹1 Cr
-₹74 Cr-₹89 Cr-₹65 Cr-₹298 Cr-₹4 Cr-₹26 Cr-₹44 Cr-₹125 Cr-₹78 Cr-₹60 Cr-₹5 Cr-₹11 Cr-₹9 Cr-₹30 Cr-₹200 Cr-₹18 Cr
-₹70 Cr-₹73 Cr-₹59 Cr-₹26 Cr-₹49 Cr-₹26 Cr-₹39 Cr-₹43 Cr-₹2 Cr-₹65 Cr-₹63 Cr-₹36 Cr-₹33 Cr-₹5 Cr₹100 Cr₹30 Cr
₹12 Cr-₹19 Cr₹17 Cr-₹184 Cr₹70 Cr₹111 Cr₹58 Cr-₹39 Cr₹36 Cr-₹18 Cr₹26 Cr₹6 Cr₹13 Cr₹7 Cr-₹12 Cr₹13 Cr
₹94 Cr₹114 Cr₹96 Cr₹267 Cr₹192 Cr₹83 Cr₹23 Cr₹61 Cr₹8 Cr₹25 Cr₹4 Cr₹2 Cr₹3 Cr₹5 Cr₹15 Cr₹2 Cr
₹0₹0₹0₹2 L₹0₹60 L₹0₹0₹15 Cr₹15 L₹0₹0₹0₹0₹0₹0
₹2 Cr-₹38 L-₹15 L₹13 Cr₹5 Cr-₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹39 L-₹5 Cr-₹4 Cr-₹15 Cr-₹9 Cr₹2 Cr₹0
₹109 Cr₹94 Cr₹114 Cr₹96 Cr₹267 Cr₹192 Cr₹83 Cr₹23 Cr₹61 Cr₹8 Cr₹25 Cr₹4 Cr₹2 Cr₹3 Cr₹5 Cr₹15 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)295.00
Volume (₹)2.06 L
High (₹)300.05
Upper Circuit356.40
Low (₹)291.85
Lower Circuit237.60
Prev Close297.00
52W High (₹)419.00
Price293.00
52W Low (₹)251.95

Share Market Cap & Key Ratios Overview

M.Cap (₹)3326.25 Cr
Div. Yield (%)1.80
PE Ratio20.05
Debt to Equity0.01
Price to Book1.76
Book Value144.99
EPS (TTM)14.81
Face Value2.00
ROE (%)11.43

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
ADVENZYMESNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
293+5.2 (1.81%)
287
302.70
3,326Cr

Advanced Enzyme Technologies Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹63.98Cr; with other income of ₹13.02Cr, profit before interest and tax came to ₹54.11Cr. Interest expense was ₹58Lakh; PBT before exceptional items stood at ₹53.53Cr. Cost mix (full year): raw materials ₹194.31Cr; employee cost ₹162.29Cr; depreciation ₹9.88Cr; other expenses ₹138.82Cr. Basis: consolidated annual results.

Advanced Enzyme Technologies Ltd Quaterly Results Key Takeaways

Advanced Enzyme Technologies Ltd reported ₹189.79Cr total income from operations in Jun 2026, softer than ₹203.37Cr in Mar 2026 but higher than ₹185.91Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹63.98Cr; with other income of ₹13.02Cr, profit before interest and tax came to ₹54.11Cr. Interest expense was ₹58Lakh, taking profit before tax to ₹53.53Cr. After tax of ₹14.94Cr, profit after tax stood at ₹38.59Cr (vs ₹45.25Cr in Mar 2026 and ₹40.44Cr in Jun 2025).